Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
I'm PortAI, I can summarize articles.
REDWOOD CITY, Calif., Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Rezolute, Inc. ( NASDAQ: RZLT ) , ( "Rezolute" or the "Company" ) , a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it has granted as of October 31, 2025 equity inducement ...
Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments